Some countries have taken stock and seek to increase inbound medical tourism while others are moving from increasing medical tourism numbers to increased revenue.
Others have decided that wellness tourism is far more lucrative than medical tourism.
Outbound medical tourism costs some countries millions of dollars in exchange revenue but produces revenue for others.
China wants medical tourists to remain in Greater China rather than going elsewhere. The myth that Asian medical tourism destinations can target customers from the USA and Western Europe is fully busted.
The reality is that medical tourists are from Asia, Eastern Europe and the Pacific.
This unique analysis of Asia-Pacific medical tourism looks forward rather than back as the pandemic changed the rules of engagement forever.
Medical tourism in 2022 and beyond will not be a restart of how it was left in 2019 and earlier as previous trends will not return. This report looks at the potential and future in the context of how Asian countries are improving healthcare.
Medical tourism is too often looked at in isolation from mainstream tourism and ignoring vital information on local healthcare, compulsory health insurance and private health insurance.
A key section profiles 12 top existing and potential medical tourism destinations for inbound and outbound.
Another section profiles another 12 leading medical tourism sources in the region.
For those new to medical tourism, there is background such as how published numbers can be misleading, the role of key accreditors and why people become medical tourists.
Key Topics Covered:
1. INTRODUCTION
Asia-Pacific country prospects
Australia
Azerbaijan
Bangladesh
Cambodia
China
Hong Kong
India
Indonesia
Japan
Kazakhstan
Laos
Macau
Malaysia
Mongolia
Myanmar
New Zealand
Pakistan
Philippines
Singapore
South Korea
Sri Lanka
Taiwan
Thailand
Uzbekistan
Vietnam
2. TOP 12 ASIA-PACIFIC DESTINATIONS
China
Hong Kong
India
Indonesia
Macau
Malaysia
Philippines
Singapore
South Korea
Taiwan
Thailand
Vietnam
Uzbekistan
